A clinical study on topical insulin in fungal keratitis with corneal epithelial defects
Bioinformation · 31.10.2026 · 22 (10) · 7174-7177
DOI: 10.6026/973206300227174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Purva Gadoeya.
Abstract (Originalsprache)
Fungal keratitis remains an important cause of corneal morbidity, particularly in tropical regions. Therefore, it is of interest to evaluate the efficacy of topical insulin in fungal keratitis with corneal epithelial defects. Hence, eighty patients with fungal keratitis and corneal epithelial defects were included. Patients received either topical insulin 1 IU/mL four times daily in addition to conventional treatment or conventional treatment alone. Mean defect breadth decreased from 4.36 +/- 2.37 to 1.97 +/- 1.86 mm with insulin and from 4.31 +/- 1.99 to 2.84 +/- 1.37 mm with conventional treatment; the corresponding reductions were 2.39 +/- 2.02 and 1.47 +/- 1.14 mm, respectively. Topical insulin is a useful, inexpensive adjunct for promoting epithelial healing, while appropriate antifungal therapy remains essential.
Zitieren
APA
Gadoeya, P. (2026). A clinical study on topical insulin in fungal keratitis with corneal epithelial defects. Bioinformation, 22(10), 7174-7177. https://doi.org/10.6026/973206300227174
Vancouver
Gadoeya P. A clinical study on topical insulin in fungal keratitis with corneal epithelial defects. Bioinformation. 2026;22(10):7174-7177. doi:10.6026/973206300227174
BibTeX
@article{Gadoeya2026,
author = {Gadoeya, Purva},
title = {A clinical study on topical insulin in fungal keratitis with corneal epithelial defects},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {7174--7177},
doi = {10.6026/973206300227174}
}
EUVIMED